Format

Send to

Choose Destination
Respirology. 2020 Mar;25(3):336-338. doi: 10.1111/resp.13771. Epub 2020 Jan 30.

Valproic acid and sleep apnoea: A disproportionality signal from the WHO pharmacovigilance database.

Author information

1
HP2 Inserm U1042, Université Grenoble Alpes, Grenoble, France.
2
Laboratoire EFCR, CHU Grenoble Alpes, Grenoble, France.
3
Centre Régional de Pharmacovigilance, CHU Grenoble Alpes, Grenoble, France.
4
Clinique du Sommeil, CHU de Bordeaux, Bordeaux, France.
5
SANPSY, Université de Bordeaux, Bordeaux, France.
6
SANPSY USR 3413, CNRS, Bordeaux, France.

KEYWORDS:

pharmacovigilance; sleep apnoea syndromes; valproic acid

PMID:
32000295
DOI:
10.1111/resp.13771
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center